tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Mitchell Kapoor, 452 are a BUY (89.5%), 40 are a HOLD (7.92%), 13 are a SELL (2.57%).
Analyst Mitchell Kapoor, carries an average stock price target met ratio of 30.85% that have a potential upside of 46.6% achieved within 74 days. Previously, Mitchell Kapoor worked at HC WAINWRIGHT.
Mitchell Kapoor’s has documented 977 price targets and ratings displayed on 39 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on GLUE, Monte Rosa Therapeutics at 05-Oct-2026.
Analyst best performing recommendations are on CBIO (CATALYST BIOSCIENCES).
The best stock recommendation documented was for SMMT (SUMMIT THERAPEUTICS PLC) at 9/9/2024. The price target of $30 was fulfilled within 4 days with a profit of $10.86 (56.74%) receiving and performance score of 141.85.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Aug-2021
$36
$-0.01 (-0.03%)
$36
3 years 11 months 18 days ago
(28-Nov-2022)
3/3 (100%)
$0.35 (0.98%)
267
Buy Since 15-Feb-2022
$36
$-0.01 (-0.03%)
$35
3 years 11 months 24 days ago
(22-Nov-2022)
3/4 (75%)
$0.4 (1.12%)
145
Buy Since 10-Aug-2021
$36
$-0.01 (-0.03%)
$35
3 years 11 months 24 days ago
(22-Nov-2022)
3/4 (75%)
$0.4 (1.12%)
204
Hold Since 22-Nov-2022
$36
$-0.01 (-0.03%)
3 years 11 months 24 days ago
(22-Nov-2022)
1/1 (100%)
$0.4 (1.12%)
48
Buy Since 28-Oct-2022
$36
$-0.01 (-0.03%)
$25
3 years 11 months 25 days ago
(21-Nov-2022)
2/2 (100%)
$0.41 (1.15%)
37
Which stock is Mitchell Kapoor most bullish on?
Which stock is Mitchell Kapoor most reserved on?
